- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,263,762
- Total 13F shares
- 108,724,328
- Share change
- -163,435
- Total reported value
- $3,548,383,679
- Put/Call ratio
- 156%
- Price per share
- $32.62
- Number of holders
- 252
- Value change
- -$11,513,808
- Number of buys
- 126
- Number of sells
- 115
Quarterly Holders Quick Answers
What is CUSIP 23282W605?
CUSIP 23282W605 identifies CYTK - CYTOKINETICS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23282W605:
Top shareholders of CYTK - CYTOKINETICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
12%
|
14,625,382
|
$514,667,193 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
10%
|
12,864,812
|
$452,712,752 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.3%
|
10,183,332
|
$358,351,453 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.1%
|
7,526,617
|
$264,861,652 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
4,753,900
|
$167,289,741 | — | 31 Mar 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2.2%
|
2,678,698
|
$94,234,380 | — | 31 Mar 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.1%
|
2,611,692
|
$91,905,441 | — | 31 Mar 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.1%
|
2,574,198
|
$90,586,028 | — | 31 Mar 2023 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.9%
|
2,399,545
|
$84,439,989 | — | 31 Mar 2023 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.9%
|
2,307,269
|
$81,193,000 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.8%
|
2,270,391
|
$79,895,059 | — | 31 Mar 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
2,100,000
|
$73,899,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,734,696
|
$61,043,976 | — | 31 Mar 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.3%
|
1,573,644
|
$55,372,968 | — | 31 Mar 2023 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.2%
|
1,518,062
|
$53,421,000 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
1,477,481
|
$51,992,557 | — | 31 Mar 2023 | |
| Artal Group S.A. |
13F
|
Company |
1.1%
|
1,367,023
|
$48,106,000 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
1,283,092
|
$45,152,010 | — | 31 Mar 2023 | |
| Logos Global Management LP |
13F
|
Company |
1%
|
1,250,000
|
$43,987,500 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.98%
|
1,203,255
|
$42,342,543 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.95%
|
1,172,029
|
$41,245,000 | — | 31 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.88%
|
1,084,644
|
$38,168,633 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.87%
|
1,074,524
|
$37,812,500 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.82%
|
1,010,925
|
$35,574,451 | — | 31 Mar 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.77%
|
952,004
|
$33,501,021 | — | 31 Mar 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.76%
|
938,072
|
$33,010,754 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.66%
|
812,244
|
$28,582,867 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.6%
|
745,307
|
$26,227,353 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.6%
|
738,159
|
$25,975,815 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.59%
|
722,681
|
$25,431,144 | — | 31 Mar 2023 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.5%
|
610,990
|
$21,500,738 | — | 31 Mar 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.49%
|
600,000
|
$21,114,000 | — | 31 Mar 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.47%
|
582,904
|
$20,512,392 | — | 31 Mar 2023 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.46%
|
564,752
|
$19,874,000 | — | 31 Mar 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
556,000
|
$19,565,640 | — | 31 Mar 2023 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.41%
|
500,385
|
$17,608,000 | — | 31 Mar 2023 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.41%
|
500,000
|
$17,595,000 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.44%
|
538,240
|
$17,433,536 | — | 31 Mar 2023 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.39%
|
486,272
|
$17,112,000 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.37%
|
457,000
|
$16,081,830 | — | 31 Mar 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.36%
|
447,600
|
$15,751,044 | — | 31 Mar 2023 | |
| Finepoint Capital LP |
13F
|
Company |
0.34%
|
413,793
|
$14,561,376 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
401,154
|
$14,116,620 | — | 31 Mar 2023 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.3%
|
375,819
|
$13,491,902 | — | 31 Mar 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.3%
|
365,348
|
$12,856,596 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.29%
|
356,070
|
$12,529,739 | — | 31 Mar 2023 | |
| David Cragg |
3/4/5
|
Chief HR & Admin Officer |
—
mixed-class rows
|
203,233
mixed-class rows
|
$12,476,231 | — | 07 Mar 2022 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.29%
|
353,796
|
$12,450,081 | — | 31 Mar 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.28%
|
351,169
|
$12,357,637 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.28%
|
344,909
|
$12,138,000 | — | 31 Mar 2023 |
Institutional Holders of CYTOKINETICS INC - Common Stock (CYTK) as of Q2 2023
As of 30 Jun 2023,
CYTOKINETICS INC - Common Stock (CYTK) was held by
252 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,724,328 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, AMERICAN CENTURY COMPANIES INC, Polar Capital Holdings Plc, RTW INVESTMENTS, LP, PFM Health Sciences, LP, and PICTET ASSET MANAGEMENT SA.
This page lists
253
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
259
Q2 2023 holders
252
Holder diff
-7
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.